Skip to main content

Table 2 Multivariate analysis for overall and progression free survival

From: Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma

 

P-value

Hazard ratio

95% CI

Overall survival

 Progression under CHT

0.029

6.06

1.2–30.3

 N° of Metastases > 3

0.029

11.76

1.29–111.11

Progression-free survival

 Progression under CHT

0.401

1.58

0.54–4.65

 N° of Metastases > 3

0.008

9.01

17.89–45.45

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us